Table 2 Clinical characteristics of study population
| Â | Han people | Ethnic Minorities | Total | P |
|---|---|---|---|---|
Mode of case-finding | ||||
 Clinical symptoms | 126 (63.0%) | 58 (58.0%) | 184 (61.3%) | 0.420 |
 Health examination | 36 (18.0%) | 22 (22.0%) | 58 (19.3%) |  |
 Screening | 38 (19.0%) | 19 (19.0%) | 57 (19.0%) |  |
 Others | 0 (0.0%) | 1 (1.0%) | 1 (0.3%) |  |
Menopause status | ||||
 Yes | 69 (34.5%) | 34 (34.0%) | 103 (34.3%) | 0.931 |
 No | 131 (65.5%) | 66 (66.0%) | 197 (65.7%) |  |
Pathological classification | ||||
 Squamous cell neoplasms | 99 (49.5%) | 47 (47%) | 146 (48.7%) | 0.908 |
 Adenocarcinoma | 18 (9.0%) | 10 (10%) | 28 (9.3%) |  |
 Others | 83 (41.5%) | 43 (43%) | 126 (42.0%) |  |
Treatment | ||||
 Cervical Conization | 63 (31.5%) | 34 (34.0%) | 97 (32.3%) | 0.523 |
 Radical Hysterectomy | 77 (38.5%) | 30 (30.0%) | 107 (35.7%) |  |
 Chemoradiotherapy | 46 (23.0%) | 28 (28.0%) | 74 (24.7%) |  |
 Adjuvant therapy | 14 (7.0%) | 8 (8.0%) | 22 (7.3%) |  |
Degree of tumor differentiation | ||||
 Not stated/given | 88 (44.0%) | 47 (47.0%) | 135 (45.0%) | 0.400 |
 Well-differentiated | 12 (6.0%) | 3 (3.0%) | 15 (5.0%) |  |
 Moderately differentiated | 47 (23.5%) | 29 (29.0%) | 76 (25.3%) |  |
 Poorly differentiated | 53 (26.5%) | 21 (21.0%) | 74 (24.7%) |  |
Contraceptive methods | ||||
 IUD | 123 (61.5%) | 63 (63.5%) | 186 (62.0%) | 0.699 |
 Condom | 35 (17.5) | 14 (14.0%) | 49 (16.3%) |  |
 Other | 23 (11.5%) | 10 (10.0%) | 33 (11.0%) |  |
 No | 19 (9.5) | 13 (13.0%) | 32 (10.7%) |  |
Stages | ||||
 CIN | 72 (36.0%) | 38 (38.0%) | 110 (36.7%) | 0.960 |
 Stage I | 64 (32.0%) | 28 (28.0%) | 92 (30.7%) |  |
 Stage II | 36 (18.0%) | 18 (18.0%) | 54 (18.0%) |  |
 Stage III | 24 (12.0%) | 14 (14.0%) | 38 (12.7%) |  |
 Stage IV | 4 (2.0%) | 2 (2%) | 6 (2.0%) |  |